Phenotypic correction of activated protein C resistance following orthotopic liver transplantation

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 1, 1996, Pages 65-68

  Foster, P A ^a,b   Varma, R R ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Activated protein C resistance; Factor V; Factor V Leiden; Liver transplantation; Platelets; Primary sclerosing cholangitis; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; PROTEIN S;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; THROMBOCYTE; THROMBOPHILIA; THROMBOSIS;

EID: 0029866659     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199601000-00008     Document Type: Article

References (17)

1. Dählback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
2. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993.
3. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506.
4. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522.
5. Cadroy Y, Sie P, Boneu B. Frequency of a defective response to activated protein C in patients with a history of venous thrombosis. Blood 1994; 83: 2008-2009.
6. Halbmeyer W-M, Haushofer A, Schon R, Fischer M. The prevalence of poor anticoagulant response to activated protein C resistance (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coag Fibrinol 1994; 5: 51-57.
7. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
8. Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR. High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br J Haemotol 1994; 88: 219-222.
9. Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of the molecular defect in FV R506Q. J Biol Chem 1995; 270: 4053-4057.
10. Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemostas 1993; 70: 1067-1071.
11. Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 1994; 83: 3120-3125.
12. Kirschbaum NE, Foster PA. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemostas 1995; 74: 874-878.
13. Foster PA, Endres-Brooks JL, Budish MA. Prevalence of activated protein C resistance in individuals with suspected type II protein S deficiency. J Invest Med 1995; 43: 232.
14. Tracy PB, Eide LL, Bowie EJW, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
15. Camire RM, Kalafatis M, Cushman M, Tracy RP, Mann KG, Tracy PB. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem 1995; 270: 20794-20800.
16. Tracy PB, Giles AR, Mann KG, Eide LL, Hoogendoorn, Rivard GE. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984; 74: 1221-1228.
17. Nesheim ME, Nichols WL, Cole TL, et al. Isolation and study of an acquired inhibitor of human coagulation factor V. J Clin Invest 1986; 77: 405-415.